{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T13:10:20Z","timestamp":1769001020864,"version":"3.49.0"},"reference-count":18,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2000,11]]},"abstract":"ABSTRACT<\/jats:title>\n \n T-cell-deficient nude mice infected with\n Leishmania donovani<\/jats:italic>\n were treated with miltefosine and then given either no treatment or intermittent miltefosine. Intracellular visceral infection recurred in untreated mice but was suppressed by once- or twice-weekly oral administration of miltefosine. Miltefosine may be useful as oral maintenance therapy for T-cell-deficient patients with visceral leishmaniasis.\n <\/jats:p>","DOI":"10.1128\/aac.44.11.3235-3236.2000","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:06:42Z","timestamp":1027764402000},"page":"3235-3236","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":27,"title":["Suppression of Posttreatment Recurrence of Experimental Visceral Leishmaniasis in T-Cell-Deficient Mice by Oral Miltefosine"],"prefix":"10.1128","volume":"44","author":[{"given":"Henry W.","family":"Murray","sequence":"first","affiliation":[{"name":"Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.10.2.298"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1997.57.75"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(92)90297-P"},{"key":"e_1_3_2_5_2","unstructured":"Desjeux\n P.\n UNAIDS\n Leishmania and HIV in gridlock. WHO and the UNAIDS WHO\/CTD\/LEISH\/98.9 Add. 1 and UNAIDS\/98.23.\n 1998\n World Health Organization\n Geneva Switzerland"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/520457"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199912093412403"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01700556"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199906180-00009"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.4.1041"},{"key":"e_1_3_2_11_2","unstructured":"Murray\n H. W.\n Granulomatous inflammation: host antimicrobial defense in the tissues in visceral leishmaniasis\n Inflammation: basic principles and clinical correlates\n 3rd ed.\n Gallin\n J.\n Synderman\n R.\n Fearon\n D.\n Haynes\n B.\n Nathan\n C.\n 1999\n 977\n 994\n Lippincott-Raven\n Philadelphia Pa"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1089\/108729199318183"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1086\/315268"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","unstructured":"Murray H. W. Treatment of kala-azar in 2000: a decade of progress and future approaches. Int. J. Infect. Dis. in press.","DOI":"10.1016\/S1201-9712(00)90078-X"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.1.1"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)89503-4"},{"key":"e_1_3_2_17_2","first-page":"263","article-title":"Antithymocyte serum suppression of immunity in mice immunized to Leishmania donovani.","volume":"20","author":"Runey G. L.","year":"1990","unstructured":"Runey G. L. Jarecki-Black J. C. Runey M. W. Glassman A. B. Antithymocyte serum suppression of immunity in mice immunized to Leishmania donovani. Ann. Clin. Lab. Sci. 20 1990 263 267","journal-title":"Ann. Clin. Lab. Sci."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)04367-0"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1999.11813462"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.44.11.3235-3236.2000","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.44.11.3235-3236.2000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T16:34:58Z","timestamp":1645461298000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.44.11.3235-3236.2000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2000,11]]}},"alternative-id":["10.1128\/AAC.44.11.3235-3236.2000"],"URL":"https:\/\/doi.org\/10.1128\/aac.44.11.3235-3236.2000","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,11]]},"assertion":[{"value":"2000-04-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-08-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}